- Arachnoid cysts, which are cerebrospinal fluid-filled sacs located within the arachnoid membrane surrounding the brain and spinal cord, are increasingly recognized as conditions requiring careful management due to their potential to cause neurological symptoms and complications in both paediatric and adult populations
- The escalating demand for arachnoid cysts treatment is primarily fueled by the rising incidence of diagnosed cases, advancements in neuroimaging technologies allowing for earlier and more accurate detection, and a growing understanding of when intervention is necessary to alleviate symptoms
- North America dominates the arachnoid cysts treatment market with the largest revenue share of 43.2% in 2024. This leadership is characterized by advanced healthcare infrastructure, high healthcare expenditure, and a strong presence of key market players involved in neurosurgery and medical device manufacturing
- Asia-Pacific is expected to be the fastest growing region in the arachnoid cysts treatment market during the forecast period, due to increasing healthcare expenditure, improving diagnostic capabilities, and rising awareness of neurological disorders in countries such as China and India, leading to a higher rate of diagnosis and treatment
- Surgery segment is a dominant or fast-growing segment in the arachnoid cysts treatment market with a revenue share of 76.2% in 2024. This dominance is driven by surgery being the definitive treatment for symptomatic arachnoid cysts, offering effective relief of pressure and symptoms
